MNKD Q3 2018 Earnings — MannKind Corporation Revenue & Financial Results | Market Cap Arena

MNKDMannKind Corporation

$841M

Q3 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M+118.7% YoY

Gross Profit

-$834,000-18.7% margin

Operating Income

-$22M-482.1% margin

Net Income

-$24M-540.8% margin

EPS (Diluted)

$-0.16

QoQ Revenue Growth

+14.8%

Cash Flow

Operating Cash Flow

-$14M

Free Cash Flow

-$14M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$45M

Total Liabilities

$251M

Stockholders' Equity

-$205M

Cash & Equivalents

$10M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$2M	+118.7%
Gross Profit	-$834,000	-$3M	+67.1%
Operating Income	-$22M	-$28M	+23.5%
Net Income	-$24M	-$33M	+26.5%

Revenue Segments

Product

$4M97%

License

$82,0002%

Product And Service Other

$53,0001%